Ads
related to: Cologuard Dna Test and Cancer Screening- Contact Us
Have Questions? Don’t Hesitate.
Contact Us Today.
- Precision Oncology
Finding Cancer's Fingerprint.
Learn More.
- Genomic Landscape
Genomics are Changing the Future
of Oncology. Learn More.
- NRG1 Fusion
More Aggressive Than You Think.
Learn About NGR1 Today.
- Contact Us
Search results
New screening guidance caught her cancer early. Soon, a blood test could give patients more options
Post-Bulletin· 2 weeks agoThe U.S. Preventive Services Task Force recommended in 2021 that adults should start being screened...
Analyst Report: Exact Sciences Corporation
Morningstar Research via Yahoo Finance· 12 hours agoExact’s Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer& ...
CRC Screening in Primary Care: The Blood Test Option
Medscape· 4 days agoWill patients who are offered this option forego colonoscopy and instead opt for a blood test?
Xponance Inc. Sells 668 Shares of Exact Sciences Co. (NASDAQ:EXAS)
ETF DAILY NEWS· 5 hours agoXponance Inc. decreased its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 5.1% in the fourth quarter, according to the company in its most recent 13F filing with the ...
10 notes on colonoscopies in 2024
Becker's ASC Review· 1 week ago1. Medtronic recently entered a partnership with EHR company ModMed to enhance documentation of its GI Genius polyp detection tool. Medtronic will input data from GI Genius into ModMed's GI-focused ...
Mackenzie Financial Corp Reduces Holdings in Exact Sciences Co. (NASDAQ:EXAS)
ETF DAILY NEWS· 6 hours agoMackenzie Financial Corp cut its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 6.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange ...
Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Crestwood Advisors Group LLC
ETF DAILY NEWS· 2 weeks agoCrestwood Advisors Group LLC lessened its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 6.3% in the 4th quarter, according to the company in its most recent Form 13F filing with ...
Daiwa Securities Group Inc. Acquires 400 Shares of Exact Sciences Co. (NASDAQ:EXAS)
ETF DAILY NEWS· 1 day agoDaiwa Securities Group Inc. lifted its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 3.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities ...
Mutual of America Capital Management LLC Sells 350 Shares of Exact Sciences Co. (NASDAQ:EXAS)
ETF DAILY NEWS· 2 days agoMutual of America Capital Management LLC lowered its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 10.0% in the 4th quarter, according to the company in its most recent 13F filing ...
Ad
related to: Cologuard Dna Test and Cancer Screening